XRAY vs ICUI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

XRAY

57.9
AI Score
VS
XRAY Wins

ICUI

55.5
AI Score

Investment Advisor Scores

XRAY

58score
Recommendation
HOLD

ICUI

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY ICUI Winner
Forward P/E 6.3291 16.9492 XRAY
PEG Ratio 0.633 0.0799 ICUI
Revenue Growth -4.1% 0.5% ICUI
Earnings Growth 15.2% -46.9% XRAY
Tradestie Score 57.9/100 55.5/100 XRAY
Profit Margin -15.0% 1.4% ICUI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: -18.8% · 3M: -25.0% ICUI 1M: -8.0% · 3M: +1.4%

Current Technical Phase

XRAY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 28

RSI (14): 28.4 · Price: $8.74

ICUI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.5 · Price: $157.18

Fundamentals Snapshot

Metric XRAY ICUI
Market Cap — —
Forward P/E 5.8 16.3
Trailing P/E — 134.9
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.5% 0.4%
Operating Margin 0.1% 0.1%
EPS -2.69 1.19
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.